PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Dr. Ralph and Marian Falk Medical Research Trust awards $1.35M to two Case Western Reserve University researchers

Funding will advance novel approaches to treating cancer and diabetes-related blindness

Dr. Ralph and Marian Falk Medical Research Trust awards $1.35M to two Case Western Reserve University researchers
2023-11-16
(Press-News.org) CLEVELAND—A combined $1.35 million from the Dr. Ralph and Marian Falk Medical Research Trust was awarded to two researchers from the Case Western Reserve University School of Medicine to advance their work on finding more effective treatments—and better options—for two debilitating diseases.

The Falk Trust awarded Reshmi Parameswaran, an assistant professor in the Department of Medicine, Division of Hematology/Oncology, pathology and pediatrics at the School of Medicine, $1 million over three years for her work in cancer cell therapy.

Carlos Subauste, a professor of medicine and pathology at the School of Medicine, received a two-year, $350,000 grant for his research in diabetic retinopathy, a leading cause of blindness.

Cancer cell therapy

Parameswaran has developed a new treatment strategy for B-cell cancer patients—especially for those who don’t respond to conventional therapies. B-cell lymphoma is a type of cancer that forms in white blood cells.

Many B-cell cancer patients don’t respond to existing therapies, and the disease returns in about half of these patients. Some patients don’t respond at all, while others may initially respond well, but then the disease returns those therapies are ineffective. About 100,000 of the 250,000 B-cell cancer patients diagnosed annually in the United States need a more effective therapy option. 

Parameswaran—also a member of the Immune Oncology Program at the Case Comprehensive Cancer Center—is building modified immune cells that have more power to kill cancer cells, without killing normal cells, and minimizing side effects. This cell therapy then could be easily injected into patients.

To build these cells, Parameswaran purifies “Natural Killer (NK)” cells—white blood cells with tumor-killing capabilities. Then a piece of DNA, called “BAFF CAR,” is inserted, which she said gives the NK cells more “specificity” and “power” to kill cancer cells, sparing normal cells.

NK cells from any donor can be used to make BAFF CAR-NK cells, she said, and when a need arises, these specialized cells can be thawed and injected into patients. Her lab hopes to validate the tumor-killing potential and safety of BAFF-CAR NK cells using mouse models with the support from the Falk Trust.

“Both pharmaceutical companies and clinicians treating B cell cancer patients have expressed a strong interest in the BAFF CAR-NK cells as a needed therapeutic,” Parameswaran said. “With this funding, we are optimistic to get this product to the clinic within three years.”

Diabetic retinopathy

Nearly 700 million people will be diagnosed with diabetes worldwide by 2040, and more than a third will develop diabetic retinopathy, Subauste said.

Diabetic macular edema, caused when blood vessels in the retina leak, is a major reason for progressive loss of vision in diabetic patients.

The disease is treated with eye injections of agents that neutralize what is called Vascular Endothelial Growth Factor (VEGF). But the treatment is only effective in about half of the patients, he said, because other inflammatory molecules can also cause the blood vessels to leak. Anti-VEGF agents only target VEGF, likely explaining why they are partially effective in treating diabetic macular edema.

Subauste and his colleagues are developing a drug that inhibits the molecule CD40, which is known to increase the production of both VEGF and inflammatory molecules in the diabetic retina.

Preliminary studies in the retinas of diabetic mice models suggests this approach may be more effective than monthly injections of anti-VEGF agents.

“Our work is positioned to lead to a novel and more effective way to treat diabetic retinopathy and avoid vision loss, without requiring monthly intra-ocular injections,” he said.

The Dr. Ralph and Marian Falk Medical Research Trust supports biomedical research with two programs: the Catalyst Research Award Program that provides seed funding to develop promising concepts, and the two-year Transformational Research Award to help researchers advance these concepts toward commercial development. 

These new awards build on the previous seven Falk Trust awards to Case Western Reserve biomedical researchers, totaling $3.5 million.

                                                        ###

 

About the Dr. Ralph and Marian Falk Medical Research Trust

The Dr. Ralph and Marian Falk Medical Research Trust was created by Marian Falk in 1979 to fund “medical research to improve treatments of the past and eventually find cures for diseases for which no definite cure is known” (Falk Catalyst Awards Program). The Medical Foundation at Health Resources in Action administers the Falk Catalyst Awards Program on behalf of Bank of America, N.A., Trustee.

About Case Western Reserve University

Case Western Reserve University is one of the country's leading private research institutions. Located in Cleveland, we offer a unique combination of forward-thinking educational opportunities in an inspiring cultural setting. Our leading-edge faculty engage in teaching and research in a collaborative, hands-on environment. Our nationally recognized programs include arts and sciences, dental medicine, engineering, law, management, medicine, nursing and social work. About 6,200 undergraduate and 6,100 graduate students comprise our student body. Visit case.edu to see how Case Western Reserve thinks beyond the possible.

END

[Attachments] See images for this press release:
Dr. Ralph and Marian Falk Medical Research Trust awards $1.35M to two Case Western Reserve University researchers Dr. Ralph and Marian Falk Medical Research Trust awards $1.35M to two Case Western Reserve University researchers 2

ELSE PRESS RELEASES FROM THIS DATE:

High levels of maternal stress during pregnancy linked to children’s behavior problems

2023-11-16
WASHINGTON – Children whose mothers are highly stressed, anxious or depressed during pregnancy may be at higher risk for mental health and behavior issues during their childhood and teen years, according to research published by the American Psychological Association. “Our research suggests that psychological distress during the pregnancy period has a small but persistent effect on children’s risk for aggressive, disinhibited and impulsive behaviors,” said study author Irene Tung, PhD, of California State University Dominguez Hills. “These findings add to the evidence that providing widely accessible mental health care and support ...

Catalyzing clinical change: The importance of representation in health care

2023-11-16
DALLAS, November 16, 2023 — Disparities in health care persist, with Hispanic and Black adults reporting less satisfaction with their interactions with physicians, leading to poorer quality of care and health outcomes.[1],[2],[3] While 19% of people in the U.S. identify as Hispanic, fewer than 7% of physicians do.[4] This lack of representation in the delivery of health care has been shown to exacerbate health disparities among underrepresented groups and is a significant barrier to the Hispanic Latino community achieving optimal health.[5] In response to this challenge, the American Heart Association, a global force for ...

Lithium-ion batteries are no longer the gold standard in battery tech

Lithium-ion batteries are no longer the gold standard in battery tech
2023-11-16
The use of lithium metal as the anode for batteries is one of the smarter options with better energy density than other materials. However, the interface between the electrode and electrolyte has quite a few issues that can be addressed for a safer and more functional outcome in the future.   The researchers are keen on replacing the graphite anode with lithium metal anode to construct a battery system with higher energy density. However, the Li metal anode is unstable and readily reacting with electrolyte to form a solid-electrolyte interphase (SEI). Unfortunately, the natural SEI is brittle and fragile, resulting in poor ...

Gene splicing reduces effectiveness of CD20-targeting monoclonal antibodies designed to treat variety of blood cancers and disorders

2023-11-16
Philadelphia, November 16, 2023 – Immunotherapies that target the CD20 antigen have revolutionized how patients with a variety of blood cancers and hematologic disorders have been treated. However, many patients develop resistance to these treatments due to a loss of the antigen that’s being targeted. Now, a new study from researchers at Children’s Hospital of Philadelphia (CHOP) and the Perelman School of Medicine at the University of Pennsylvania (Penn) has found that gene splicing occurring within these cells can cause significant changes in CD20 protein levels that render the therapies ineffective. The findings, published today by ...

IVI signs MOU with University of Cambridge, University of Hong Kong, and the Hong Kong Jockey Club to establish the Hong Kong Jockey Club Global Health Institute

IVI signs MOU with University of Cambridge, University of Hong Kong, and the Hong Kong Jockey Club to establish the Hong Kong Jockey Club Global Health Institute
2023-11-16
November 16, 2023, Republic of Korea  — The International Vaccine Institute (IVI), an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health, signed an MOU yesterday with University of Cambridge (UCAM), University of Hong Kong (HKU), and the Hong Kong Jockey Club (HKJC) to promote vaccine research and global health initiatives, including the establishment of the Hong Kong Jockey Club Global Health Institute (HKJCGHI).   HKJC will support the HKJCGHI through one of their largest donations in history, ...

Incidence of recurrence and time to recurrence in Stage I to III colorectal cancer

2023-11-16
About The Study: In this study of 34,000 patients with colorectal cancer (CRC) who underwent surgery from 2004 to 2019, the risk of recurrence decreased over time, and higher disease stage was associated with shorter times from surgery to recurrence. Screening-detected CRC was associated with a lower risk of recurrence. Because the risk of recurrence was so low in selected patient groups, future research is warranted to explore risk-stratified surveillance protocols in patients with CRC.  Authors: Claus Lindbjerg Andersen, Ph.D., of Aarhus University Hospital in Aarhus, Denmark, ...

New efforts to improve cardiovascular, stroke care in rural areas

2023-11-16
DALLAS, November 16, 2023 — Cardiovascular mortality is on the rise in rural areas of the United States, where more than 60 million Americans live, according to an American Heart Association presidential advisory. Understanding and addressing the unique health needs of people in rural America is critical to the Association’s pursuit of a world of longer, healthier lives. Today — on National Rural Health Day — the Association, the world’s leading nonprofit organization focused on heart and brain health for all, announces two new collaborative efforts to help close the gap between ...

Make a list, check it twice with these heart-healthy holiday travel hacks

2023-11-16
DALLAS, Nov. 16, 2023 — For people living with a health condition like heart disease or stroke, traveling away from home can pose some special challenges. The American Heart Association, the leading voluntary health organization devoted to a world of longer, healthier lives for all, says with a little pre-travel prep, you can turn travel woes from “oh no” to “let’s go!” “As we look forward to the holidays, many people will be traveling to spend treasured time with family and friends, or maybe just to enjoy some ...

Two new clinical trials find first-ever safe and effective treatment to prevent multidrug-resistant TB in both children and adults: Results presented at the Union Conference in Paris

2023-11-16
PARIS (16 November, 2023)—Two landmark clinical trials reported today at the Union meeting showed that an oral antibiotic taken for six months once-daily substantially reduced the risk of developing drug-resistant TB. The antibiotic levofloxacin safely reduced the risk of multidrug-resistant (MDR) tuberculosis (TB) disease in children by 56%, researchers from the Desmond Tutu TB Centre at Stellenbosch University announced at the Union Conference in Paris today. The Unitaid-funded trial also showed that levofloxacin given once ...

AI model can help predict survival outcomes for patients with cancer

2023-11-16
Investigators from the UCLA Health Jonsson Comprehensive Cancer Center have developed an artificial intelligence (AI) model based on epigenetic factors that is able to predict patient outcomes successfully across multiple cancer types. The researchers found that by examining the gene expression patterns of epigenetic factors — factors that influence how genes are turned on or off — in tumors, they could categorize them into distinct groups to predict patient outcomes across various cancer types better than traditional measures like cancer grade and stage. These findings, described in Communications Biology, also lay the groundwork ...

LAST 30 PRESS RELEASES:

Researchers take broadband high-resolution frequency combs into the UV

Not going out is the “new normal” post-Covid, say experts

Study shows broader screening methods help prevent spread of dangerous fungal pathogen in hospitals

Research spotlight: Testing a model for depression care in Malawi using existing medical infrastructure

Depression care in low-income nations can improve overall health

The BMJ investigates dispute over US group’s involvement in WHO’s trans health guideline

Personal info and privacy control may be key to better visits with AI doctors

NIH study demonstrates long-term benefits of weight-loss surgery in young people

Sustained remission of diabetes and other obesity-related conditions found a decade after weight loss surgery in adolescence

Low-level lead poisoning is still pervasive in the US and globally

How researchers can maximize biological insights using animal-tracking devices

Research shows new method helps doctors safely remove dangerous heart infections without surgery

Rapid horizontal eye movement can improve stability in people with Parkinson’s

Study finds COVID-19 pandemic worsened patient safety measures

Costs still on the rise for drugs for neurological diseases

Large herbivores have lived in Yellowstone National Park for more than 2,000 years

Antarctic penguin colonies can be identified and tracked from tourists' photos, using a computer model to reconstruct the 3D scene

For patients with alcohol use disorder, exercise not only reduces alcohol dependence, but also improves mental and physical health, per systematic review

Bones from Tudor Mary Rose shipwreck suggest handedness might affect collarbone chemistry

Farewell frost! New surface prevents frost without heat

Similarities in brain development between marmosets and humans

Can we protect nerve cells from dying?

Why does Lake Geneva emit large quantities of CO2? UNIL scientists provide the answer and solve a scientific enigma

Double strike against blood cancer

Combining VR and non-invasive brain stimulation: a neurotechnology that boosts spatial memory without surgery

A rudimentary quantum network link between Dutch cities

Accounting for bias in medical data helps prevent AI from amplifying racial disparity

MD Anderson Research Highlights for October 30, 2024

Three Baycrest leaders named 2024 Canada’s Most Powerful Women: WXN’s Top 100 Award winners

Scientists uncover new mechanism in plant cold sensing

[Press-News.org] Dr. Ralph and Marian Falk Medical Research Trust awards $1.35M to two Case Western Reserve University researchers
Funding will advance novel approaches to treating cancer and diabetes-related blindness